Thanks skorpian great input.
In respect of another previous question here regarding OSL being either a single product company or does it have other products on the go, which I would doubt at this stage of the Company's life, I am under the impression their technology might be described as 'platform technology' which in effect must mean their process could be applied to other cancer types. Can you advise if this is correct please?
thanks
redgum
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
0.005(0.43%) |
Mkt cap ! $16.35M | |||
| Open | High | Low | Value | Volume |
| $1.19 | $1.20 | $1.15 | $15.98K | 13.70K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11028 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 23 | 1 |
View Market Depth
| Last trade - 11.01am 30/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |